Building in Houston expands Eli Lilly’s United States production at a time when its competitor, Novo Nordisk, maker of ...

One of them is already a leader in the market for weight management drugs, and the other could join this field.

The struggling Danish company says it looks to reorganize, with the impact on North Carolina workers still unclear.

The Institute for Clinical and Economic Review (ICER) on Tuesday released a Draft Evidence Report assessing the comparative ...

Novo Nordisk will lay off 9,000 employees worldwide as part of a restructuring plan, redirecting savings to diabetes and obesity drug growth.

The draft assessment finds that the popular weight loss drugs are costly but worth the price tag, while also urging for ...

The restructuring, which would eliminate 11% of the company's workforce, aimed to reduce organizational complexity and speed ...

Novo Nordisk , the maker of blockbuster weight-loss drug Wegovy, said on Wednesday it will cut 9,000 jobs in a bid to ...

Novo Nordisk announces a major restructuring, including 9,000 job cuts, to save $1.25 billion annually and regain market ...

Novo Nordisk, the maker of weight loss drug Wegovy, will lay off about 9,000 people as it grapples with rising competition in ...

Novo Nordisk said the job cuts will eliminate about 11% of its workforce, with 5,000 of the reductions in Denmark.

GLP-1 medications like Ozempic show promise for multiple health conditions, as experts explore microdosing benefits for blood ...